Cargando…
Targeting Lipooligosaccharide (LOS) for a Gonococcal Vaccine
The increasing incidence of gonorrhea worldwide and the global spread of multidrug-resistant strains of Neisseria gonorrhoeae, constitute a public health emergency. With dwindling antibiotic treatment options, there is an urgent need to develop safe and effective vaccines. Gonococcal lipooligosaccha...
Autores principales: | Gulati, Sunita, Shaughnessy, Jutamas, Ram, Sanjay, Rice, Peter A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6400993/ https://www.ncbi.nlm.nih.gov/pubmed/30873172 http://dx.doi.org/10.3389/fimmu.2019.00321 |
Ejemplares similares
-
Preclinical Efficacy of a Lipooligosaccharide Peptide Mimic Candidate Gonococcal Vaccine
por: Gulati, Sunita, et al.
Publicado: (2019) -
Effect of gonococcal lipooligosaccharide variation on human monocytic cytokine profile
por: Patrone, Julia B, et al.
Publicado: (2007) -
α-2,3-Sialyltransferase Expression Level Impacts the Kinetics of Lipooligosaccharide Sialylation, Complement Resistance, and the Ability of Neisseria gonorrhoeae to Colonize the Murine Genital Tract
por: Lewis, Lisa A., et al.
Publicado: (2015) -
Expression of paragloboside-like lipooligosaccharides may be a necessary component of gonococcal pathogenesis in men
Publicado: (1991) -
Development of Complement Factor H–Based Immunotherapeutic Molecules in Tobacco Plants Against Multidrug-Resistant Neisseria gonorrhoeae
por: Shaughnessy, Jutamas, et al.
Publicado: (2020)